NCT05380401View on ClinicalTrials.gov

Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

NARecruitingINTERVENTIONAL
Enrollment

328

Participants

Timeline

Start Date

March 9, 2023

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2028

Conditions
Premature
Interventions
DIETARY_SUPPLEMENT

Enfamil® DHA & ARA Supplement for Special Dietary Use

Dosage: 60 mg/kg/day of DHA and 120 mg/kg/day of ARA. Route of administration: enteral tube or by oral syringe

Trial Locations (7)

10021

RECRUITING

Weill Cornell Medicine, New York

60611

RECRUITING

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

RECRUITING

Northwestern University, Chicago

78229

RECRUITING

University Health System, San Antonio

RECRUITING

University of Texas Health Science Center at San Antonio, San Antonio

90404

RECRUITING

University of California, Los Angeles (UCLA), Los Angeles

06511

RECRUITING

Yale New Haven Hospital, New Haven

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

The University of Texas Health Science Center at San Antonio

OTHER